Tulip Combi 10 mg/ 20 mg filmom obložene tablete
| Name | Tulip Combi 10 mg/ 20 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-282843990 |
| Active Substance | ezetimib atorvastatinkalcij trihidrat |
| Composition | jedna filmom obložena tableta sadrži 10 mg ezetimiba i 20 mg atorvastatina (u obliku kalcijevog trihidrata) |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Elpen Pharmaceutical Co.Inc. (SA), Pikermi, Attica, Grčka Lek Pharmaceuticals d.d., Ljubljana, Slovenija Elpen Pharmaceutical Co.Inc. (SA), Keratea, Grčka |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 11.11.2021 |
| MA Period of Validity | 11.11.2026 |
| Classification Number | UP/I-530-09/20-01/102 |
| Registration Number | 381-12-01/38-21-02 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C10BA05 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
